BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Mar 24, 12:08Prev. Close
84.78
Open Price
87.80
Bid Price (Qty.)
85.27 (1)
Offer Price (Qty.)
85.90 (46)
| Key Financial Ratios of Par Drugs & Chemicals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | |
| Per Share Ratios | |||||
| Basic EPS (Rs.) | 3.28 | 2.68 | 3.34 | 4.16 | |
| Diluted EPS (Rs.) | 3.28 | 2.68 | 3.34 | 4.16 | |
| Cash EPS (Rs.) | 11.92 | 10.72 | 6.75 | 7.00 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 41.76 | 38.54 | 35.86 | 32.53 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 41.76 | 38.54 | 35.86 | 32.53 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 123.14 | 101.01 | 69.23 | 69.50 | |
| PBDIT/Share (Rs.) | 27.45 | 26.98 | 11.43 | 12.25 | |
| PBIT/Share (Rs.) | 18.81 | 18.94 | 8.02 | 9.41 | |
| PBT/Share (Rs.) | 4.53 | 4.47 | 4.98 | 6.34 | |
| Net Profit/Share (Rs.) | 3.28 | 2.68 | 3.34 | 4.16 | |
| Profitability Ratios | |||||
| PBDIT Margin (%) | 22.28 | 26.70 | 16.51 | 17.62 | |
| PBIT Margin (%) | 15.27 | 18.74 | 11.58 | 13.54 | |
| PBT Margin (%) | 3.67 | 4.42 | 7.18 | 9.12 | |
| Net Profit Margin (%) | 2.66 | 2.65 | 4.81 | 5.98 | |
| Return on Networth / Equity (%) | 7.86 | 6.95 | 9.30 | 12.78 | |
| Return on Capital Employed (%) | 12.82 | 11.86 | 4.78 | 11.02 | |
| Return on Assets (%) | 1.51 | 1.17 | 1.71 | 3.90 | |
| Total Debt/Equity (X) | 2.47 | 3.20 | 3.31 | 1.18 | |
| Asset Turnover Ratio (%) | 56.74 | 44.42 | 35.48 | 65.18 | |
| Liquidity Ratios | |||||
| Current Ratio (X) | 0.68 | 0.75 | 1.28 | 1.50 | |
| Quick Ratio (X) | 0.47 | 0.56 | 0.81 | 0.87 | |
| Inventory Turnover Ratio (X) | 8.36 | 7.82 | 5.41 | 5.11 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | |||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 |
25.02.2026
Par Drugs Standalone December 2025 Net Sales at Rs 29.34 crore, up 37.22% Y-o-Y
27.11.2025
Par Drugs Standalone September 2025 Net Sales at Rs 28.66 crore, down 17.31% Y-o-Y
22.08.2025
Par Drugs Standalone June 2025 Net Sales at Rs 26.05 crore, up 15.22% Y-o-Y
12.05.2025
Par Drugs Standalone March 2025 Net Sales at Rs 22.33 crore, down 2.14% Y-o-Y
24.03.2026
Accumulate Paradeep Phosphates; target of Rs 120: Prabhudas Lilladher
24.03.2026
GSP Crop Science shares make decent market debut to list at 4% premium
22.03.2026
20.03.2026
17.01.2026
Himadri Speciality Chemical Q3 profit grows 36% to 192 crore
29.07.2025
Asian Paints Q1 results: Net profit declines 6% to Rs 1,100 crore, in line with estimates
29.07.2025
28.07.2025
14.10.2025
Finolex Industries Q2 PAT seen up 136.8% YoY to Rs. 96.3 cr: Prabhudas Lilladher
09.10.2025
Vinati Organics Q2 PAT seen up 20.3% YoY to Rs 127.6 cr: Prabhudas Lilladher
09.10.2025
PCBL Chemical Q2 PAT may dip 34.6% YoY to Rs 80.7 cr: Prabhudas Lilladher
09.10.2025
PI Industries Q2 PAT may dip 8.9% YoY to Rs 462.9 cr: Prabhudas Lilladher
28.01.2026
12.01.2026
Solar Industries: Will its business strategy lead to explosive growth?
05.02.2025
11.08.2023